Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $246.16 million. The enterprise value is $49.34 million.

Market Cap	246.16M
Enterprise Value	49.34M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 161.95 million shares outstanding. The number of shares has increased by 24.37% in one year.

Current Share Class	161.95M
Shares Outstanding	161.95M
Shares Change (YoY)	+24.37%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	5.30%
Owned by Institutions (%)	35.35%
Float	86.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.43
P/TBV Ratio	1.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.54, with a Debt / Equity ratio of 0.11.

Current Ratio	10.54
Quick Ratio	10.28
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.37% and return on invested capital (ROIC) is -56.27%.

Return on Equity (ROE)	-89.37%
Return on Assets (ROA)	-52.63%
Return on Invested Capital (ROIC)	-56.27%
Return on Capital Employed (ROCE)	-130.53%
Revenue Per Employee	n/a
Profits Per Employee	-$2.29M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $183,000 in taxes.

Income Tax	183,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.36% in the last 52 weeks. The beta is 2.95, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	2.95
52-Week Price Change	-87.36%
50-Day Moving Average	1.65
200-Day Moving Average	2.47
Relative Strength Index (RSI)	41.02
Average Volume (20 Days)	369,781

Short Selling Information

The latest short interest is 5.23 million, so 3.23% of the outstanding shares have been sold short.

Short Interest	5.23M
Short Previous Month	5.28M
Short % of Shares Out	3.23%
Short % of Float	6.08%
Short Ratio (days to cover)	7.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-264.54M
Pretax Income	-273.79M
Net Income	-252.09M
EBITDA	-264.06M
EBIT	-264.54M
Earnings Per Share (EPS)	-$1.57

Balance Sheet

The company has $217.59 million in cash and $19.96 million in debt, giving a net cash position of $197.63 million or $1.22 per share.

Cash & Cash Equivalents	217.59M
Total Debt	19.96M
Net Cash	197.63M
Net Cash Per Share	$1.22
Equity (Book Value)	182.88M
Book Value Per Share	1.13
Working Capital	201.75M

Cash Flow

In the last 12 months, operating cash flow was -$195.68 million and capital expenditures $775,000, giving a free cash flow of -$194.90 million.

Operating Cash Flow	-195.68M
Capital Expenditures	775,000
Free Cash Flow	-194.90M
FCF Per Share	-$1.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.37%
Shareholder Yield	-24.37%
Earnings Yield	-102.07%
FCF Yield	-78.92%

Analyst Forecast

The average price target for NMRA is $7.14, which is 369.74% higher than the current price. The consensus rating is "Buy".

Price Target	$7.14
Price Target Difference	369.74%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-37.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1